A detailed history of Morgan Stanley transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Morgan Stanley holds 277,609 shares of STTK stock, worth $302,593. This represents 0.0% of its overall portfolio holdings.

Number of Shares
277,609
Previous 219,793 26.3%
Holding current value
$302,593
Previous $848,000 14.15%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.0 - $4.85 $173,448 - $280,407
57,816 Added 26.3%
277,609 $968,000
Q2 2024

Oct 17, 2024

BUY
$3.56 - $11.18 $419,364 - $1.32 Million
117,799 Added 115.5%
219,793 $848,000
Q2 2024

Aug 14, 2024

BUY
$3.56 - $11.18 $419,364 - $1.32 Million
117,799 Added 115.5%
219,793 $848,000
Q1 2024

Oct 17, 2024

SELL
$7.37 - $10.09 $868,178 - $1.19 Million
-117,799 Reduced 53.6%
101,994 $911,000
Q1 2024

Aug 16, 2024

BUY
$7.37 - $10.09 $671,473 - $919,289
91,109 Added 837.01%
101,994 $911,000
Q1 2024

May 15, 2024

BUY
$7.37 - $10.09 $671,473 - $919,289
91,109 Added 837.01%
101,994 $911,000
Q4 2023

Aug 16, 2024

SELL
$1.37 - $7.24 $286,203 - $1.51 Million
-208,908 Reduced 95.05%
10,885 $77,000
Q4 2023

Feb 13, 2024

BUY
$1.37 - $7.24 $10,698 - $56,537
7,809 Added 253.87%
10,885 $77,000
Q2 2023

Aug 14, 2023

SELL
$2.52 - $3.66 $55,034 - $79,930
-21,839 Reduced 87.65%
3,076 $9,000
Q1 2023

May 15, 2023

BUY
$2.5 - $4.72 $53,530 - $101,064
21,412 Added 611.25%
24,915 $73,000
Q4 2022

Feb 14, 2023

SELL
$1.96 - $3.26 $1 Million - $1.67 Million
-512,467 Reduced 99.32%
3,503 $8,000
Q3 2022

Nov 14, 2022

SELL
$2.6 - $5.52 $688,459 - $1.46 Million
-264,792 Reduced 33.91%
515,970 $1.39 Million
Q2 2022

Oct 27, 2022

SELL
$2.7 - $4.59 $182,722 - $310,628
-67,675 Reduced 7.98%
780,762 $3.17 Million
Q2 2022

Aug 15, 2022

SELL
$2.7 - $4.59 $182,722 - $310,628
-67,675 Reduced 7.98%
780,762 $3.17 Million
Q1 2022

Oct 27, 2022

BUY
$4.22 - $8.89 $285,588 - $601,630
67,675 Added 8.67%
848,437 $3.61 Million
Q1 2022

May 13, 2022

SELL
$4.22 - $8.89 $1.92 Million - $4.04 Million
-454,345 Reduced 34.87%
848,437 $3.61 Million
Q4 2021

Feb 14, 2022

BUY
$8.36 - $21.08 $8.72 Million - $22 Million
1,043,410 Added 402.28%
1,302,782 $11.1 Million
Q3 2021

Nov 15, 2021

BUY
$17.57 - $28.95 $4.56 Million - $7.51 Million
259,372 New
259,372 $5.29 Million

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $46.2M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.